VPVera S. Prokopchuk

Vera S. Prokopchuk

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Vera S. Prokopchuk has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Extended algorithm for examination of a patient with neurotrophic keratopathy: case report

    by Vera S. Prokopchuk, Vitaly V. Potemkin, Sergey Yu. Astakhov, Albina R. Potemkina, Natalia Yu. Gavrilova, Denis A. Andreev

    Neurotrophic keratopathy is a rare degenerative corneal disease caused by impaired corneal innervation and characterized by reduced corneal sensitivity and trophic changes that may lead to the development and persistence of corneal defects. The diversity of etiological factors, the absence of pronounced corneal syndrome, and the similarity of early manifestations to other ocular surface disorders frequently result in delayed diagnosis and complicate treatment selection. Therefore, a comprehensive approach to the examination of patients with neurotrophic keratopathy remains highly relevant, as it allows objective assessment of disease severity and monitoring of pathological changes during treatment. Report the case of a 69-year-old woman with a persistent postherpetic corneal erosion of the right eye lasting for four months and refractory to conservative treatment. The patient complained of decreased vision and a foreign body sensation. Best-corrected visual acuity was 0.08. Slit-lamp examination revealed an epithelial defect involving 7.6% of the corneal surface, accompanied by perifocal and stromal edema. Corneal sensitivity was absent at all nine examined points. Anterior segment optical coherence tomography demonstrated a minimum corneal thickness of 609 μm. In vivo confocal microscopy revealed marked depletion of the subbasal nerve plexus, with a corneal nerve fiber density of 4 fibers/mm2, a corneal nerve branch density of 3 branches/mm2, and a corneal nerve fiber length of 662 mm/mm2. An extended diagnostic algorithm incorporating clinical, functional, and instrumental examinations was used for comprehensive assessment of the ocular surface and subsequent follow-up. Following sublimbal orbital fat transposition (S-LOFT), involving transposition of the inferomedial orbital fat pad beneath a scleral flap to the limbal area, complete corneal epithelialization was achieved, with no recurrence of epithelial defects during the 12-month follow-up post-S-LOFT period. This clinical case demonstrates the practical value of an extended diagnostic algorithm for patients with neurotrophic keratopathy. Comprehensive evaluation of the ocular surface enables timely diagnosis, objective assessment of pathological changes, rational selection of treatment strategy, and monitoring of therapeutic outcomes.

  • Choice of treatment strategy for corneal opacities in patients with mucopolysaccharidosis type VI

    by S.V. Trufanov, V.S. Prokopchuk, I.A. Riks

    Mucopolysaccharidoses (MPSs) are a group of rare disorders caused by inherited defects of lysosomal enzymes, leading to widespread intra- and extracellular accumulation of glycosaminoglycans (GAGs). The use of enzyme replacement therapy (ERT) and hematopoietic stem cell transplantation has significantly reduced the systemic manifestations of MPS but has little effect on the severity of corneal opacity in ophthalmic involvement. Therefore, the choice of the management strategy for patients with these disorders remains a complex and relevant issue. Only a limited number of studies have addressed the treatment of corneal opacity in MPS, and publications by Russian authors on this topic are lacking. We observed 3 patients (6 eyes) with genetically confirmed MPS type VI and corneal opacity. All of them received systemic therapy; however, despite that, functional outcomes did not improve, leading to the need for keratoplasty in one of the patients. This article presents these clinical cases and discusses the therapeutic strategy for corneal opacity in patients with MPS type VI.

  • Open Access

    Sublimbal orbital fat transposition in neurotrophic keratopathy: a case series

    by Vitaliy V. Potemkin, Vera S. Prokopchuk, Sergey Yu. Astakhov, Liliia K. Anikina, Vladimir V. Petukhov, Tatiana S. Varganova, Астахов Сергей Юрьевич

    Neurotrophic keratopathy is a progressive condition resulting from corneal denervation, leading to the development and persistence of corneal ulcers. Among the pathogenetic treatment methods there are corneal neurotization, a technically challenging approach associated with a prolonged rehabilitation period, and the usage of recombinant human nerve growth factor (cenegermin), which is practically inaccessible due to its high cost and lack of registration in Russian Federation. We propose a technique of orbital fat transposition to the sclerocorneal pocket for the treatment of persistent ulcers associated with neurotrophic keratopathy. This method is based on neuronal embryology of orbital adipose tissue, as well as the abundance of neurotrophic factors and stem cells. This method was applied to three patients with different etiologies of neurotrophic keratopathy, reaching the observation endpoint in two months after the operation. Visual acuity was ranging from 0.005 to 0.01. All patients received standard therapy for 1–2 months without significant improvement. Surgery was then performed using the proposed technique, which involves repositioning the medial and central orbital fat pads into the sclerocorneal pocket. In the postoperative period, partial epithelialization was observed in all patients during the first week, followed by complete healing and scar formation. The maximum visual acuity in 2 months ranged from 0.06 to 0.3.


  • Open Access

    A clinical case of the development of choroidal neovascularization in a patient with skin melanoma on the background of therapy with MEK and BRAF inhibitors

    by Natalia V. Tkachenko, Svetlana G. Belekhova, Natalia V. Zhukova, Vera S. Prokopchuk, Natalya S. Chernova

    The emergence of targeted therapy has become a significant breakthrough in the management of cancer patients, but even it is not without drawbacks. The article describes a clinical case of the development choroidal neovascularization in a 42-year-old patient with stage IV skin melanoma during 15 months of therapy with MEK and BRAF inhibitors. Clinicians need to remember that such patients may have not only MEK-associated retinopathy, but also other pathological changes in the retina, in particular choroidal neovascularization, which may be associated with both the chemotherapy they receive and the paraneoplastic syndrome itself against the background of the course of the underlying disease. Timely diagnosis and adequate management tactics allow such patients to preserve visual functions.